Showing results (91-100 of 109) with videos related to

Sort By:
Pageof 11
Molecular Neurodegeneration|November 4, 2025
M102 activates both NRF2 and HSF1 transcription factor pathways and is neuroprotective in cell and animal models of amyotrophic lateral sclerosisAmy F Keerie, Raquel Rua Martins, Chloe F Allen, et al.
Nature Cell Biology|March 19, 2026
Paraspeckle condensation is controlled via TDP-43 polymerization and linked to neuroprotectionRachel E Hodgson, Wan-Ping Huang, Ruaridh Lang, et al.
Nature Communications|July 6, 2017
SRSF1-dependent nuclear export inhibition of C9ORF72 repeat transcripts prevents neurodegeneration and associated motor deficitsGuillaume M Hautbergue, Lydia M Castelli, Laura Ferraiuolo, et al.
Annals of Clinical and Translational Neurology|May 22, 2024
Mutations in the tail and rod domains of the neurofilament heavy-chain gene increase the risk of ALSHeather Marriott, Thomas P Spargo, Ahmad Al Khleifat, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 10, 2023
Clinical testing panels for ALS: global distribution, consistency, and challengesAllison A Dilliott, Ahmad Al Nasser, Marwa Elnagheeb, et al.
European Journal of Human Genetics : EJHG|February 16, 2025
An observational study of pleiotropy and penetrance of amyotrophic lateral sclerosis associated with CAG-repeat expansion of ATXN2Koen C Demaegd, Aoife Kernan, Johnathan Cooper-Knock, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 13, 2025
Oligogenic structure of amyotrophic lateral sclerosis has genetic testing, counselling and therapeutic implicationsAlfredo Iacoangeli, Allison A Dilliott, Ahmad Al Khleifat, et al.
Frontiers in Cellular Neuroscience|March 20, 2023
Large-scale analyses of CAV1 and CAV2 suggest their expression is higher in post-mortem ALS brain tissue and affects survivalBrett N Adey, Johnathan Cooper-Knock, Ahmad Al Khleifat, et al.
Pageof 11